clinical trial · NCT05106387
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
Chronic Kidney Disease (CKD)Noninterventional
brief summary
The main purpose of this study is to continue to see how vonsetamig works in the body and to monitor the outcomes after kidney transplant for participants previously treated in the R5459-RT-1944 study (NCT05092347). No study drug will be given during this study.
started
Oct 19, 2023
primary completion
Jun 15, 2026
completion
Feb 23, 2028
last updated
Apr 17, 2026
official title
A Noninterventional Extension Study for Patients Treated in Study R5459-RT-1944 With Vonsetamig (BCMA x CD3 Bispecific Antibody) Who Receive a Kidney Transplant
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol